SEC Form 4 · accession 0001140361-15-040640
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn L Cooper M.D.
Director
Period of report
Nov 9, 2015
Accepted (ET)
Nov 12, 2015 · 8:25 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 9, 2015 | A | 1,000 | $26.5635 | A | 35,331 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1$26.5635 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.55 to $26.5951, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.